50 filings
8-K
Liquidia Corporation
18 Nov 20
Liquidia Closes Acquisition of RareGen
4:03pm
8-K
Liquidia Corporation
16 Nov 20
Liquidia Announces Results of Special Meeting of Stockholders
7:21am
8-K
Liquidia Corporation
9 Nov 20
Liquidia Reports Third Quarter 2020 Financial Results and Provides Corporate Update
7:20am
8-K
Liquidia Corporation
2 Nov 20
Liquidia Reschedules Special Meeting of Stockholders and Reaffirms Recommendation to Approve Proposed Acquisition of RareGen, LLC
8:04am
8-K
Liquidia Corporation
19 Oct 20
Liquidia Announces Postponement of Special Meeting of Stockholders
8:35am
8-K
hiv3n5o lc9lsh
14 Oct 20
Liquidia Provides Update on U.S. Patent Trial and Appeal Board Decision on Inter Partes Review of Two United Therapeutics’ Tyvaso® Patents
4:16pm
8-K
5h4w mxiz
20 Aug 20
Liquidia Announces Chief Financial Officer Transition
9:20am
8-K
hz4xdh46b b7vh4k8
10 Aug 20
Liquidia Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:20am
8-K
69mz phuxtljuodbp
24 Jul 20
Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of New Tyvaso Patent
11:00am
8-K
c5zyra0uv7
2 Jul 20
Liquidia Announces Proposed Offering of Common Stock
4:30pm
8-K
db6x1vbzt al
29 Jun 20
Liquidia to Acquire RareGen, LLC, and Expand Presence in PAH
4:06pm
8-K
xh62en d56j7k8
19 Jun 20
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
kv8qs8wke6gnd
5 Jun 20
Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of Tyvaso Patents
3:34pm
8-K
d46wp
18 May 20
Liquidia Appoints Tushar Shah, M.D., as Chief Medical Officer
4:30pm
8-K
0nwumc7y
11 May 20
Liquidia Reports First Quarter 2020 Financial Results and Provides Corporate Update
4:10pm
8-K
qyiqxg
30 Apr 20
Liquidia Releases Final LIQ861 Results from Pivotal Phase 3 INSPIRE Study in Patients with Pulmonary Arterial Hypertension
7:40am
8-K
hdi6rkol mt
13 Apr 20
Other Events
10:19am
8-K
n7yt psux67h
8 Apr 20
Other Events
7:56am
8-K
uixgcoibt
30 Mar 20
Other Events
4:30pm
8-K
3ldwp6p4
20 Mar 20
Departure of Directors or Certain Officers
4:30pm